SCHEMBL7640674

SCHEMBL7640674

COC(=O)C1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(N(C=O)CCCN2CCC(c3ccccn3)CC2)C(=O)N1

nearest known ligand 0.59

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 18/20 0.59
ADRA1D P25100 15/20 0.48
ADRA1B P35368 15/20 0.48
MCHR1 Q99705 3/20 0.41
DRD2 P14416 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL7638484 0.96 ADRA1A (0.55) ADRA1AADRA1DADRA1BMCHR1DRD2
Hydrochloric Acid SCHEMBL6787204 0.93 ADRA1A (0.58) ADRA1AADRA1DADRA1B
SCHEMBL6729949 0.92 ADRA1A (0.63) ADRA1AADRA1DADRA1BMCHR1DRD2
SCHEMBL6710985 0.91 ADRA1A (0.71) ADRA1AADRA1DADRA1BMCHR1DRD2
Hydrochloric Acid SCHEMBL6848930 0.91 ADRA1A (0.70) ADRA1AADRA1DADRA1BMCHR1DRD2
Hydrochloric Acid SCHEMBL6782753 0.87 ADRA1A (0.51) ADRA1AADRA1DADRA1B
SCHEMBL6782417 0.86 ADRA1A (0.63) ADRA1AADRA1DADRA1BMCHR1DRD2
SCHEMBL6787228 0.86 ADRA1A (0.58) ADRA1AADRA1DADRA1BMCHR1DRD2
SCHEMBL8134486 0.85 ADRA1A (0.65) ADRA1AADRA1DADRA1BMCHR1DRD2
Hydrochloric Acid SCHEMBL6782195 0.85 ADRA1A (0.63) ADRA1AADRA1DADRA1BMCHR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410554-B1 ADRENERGIC ANTAGONIST MERCK & CO., INC. 2002-06-25 US disclosed
US-6320049-B1 PREPARING 1-AMINOCARBONYL-5-ACYLDEHYDROPYRIMIDONES BY DEPROTONATING 5-ACYLDIHYDROPYRIMIDINONES COMPOUND AND THEN COUPLING THE DEPROTONATED DERIVATIVE WITH A PRIMARY AMINE MERCK & CO., INC. 2001-11-20 US disclosed
US-6207444-B1 CONTACTING RACEMIC COMPOUND WITH PROTEINASE K, SUBTILISIN, OR A PROTEASE ENZYME FROM METARHIZIUM TO FORM ENANTIOMORPH; CHEMICAL INTERMEDIATE OF DRUG WHICH TREATS BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. 2001-03-27 US disclosed